Masimo Corporation (MASI) analyst actions
Rating and price-target actions on MASI in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MASI overview →
1 measured MASI analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Leading Proxy Advisory Firm Glass Lewis Reiterates Recommendation That Masimo Shareholders Vote FOR Both of Politan’s Independent Director Nominees | Press release | -0.25% | -0.63% |
Keep exploring
More MASI: earnings → · SEC filings → · MASI overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Anavex Life Sciences Corp. (AVXL) | 839 | -0.10% | 46% |
| Assertio Holdings, Inc. (ASRT) | 833 | -0.02% | 46% |
| SeaSpine Holdings Corporation (SPNE) | 830 | 0.00% | 45% |
| BioPlus Acquisition Corp. (BIOS) | 822 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.